Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
Keep CALM and Use Biomarkers in Inflammatory Bowel Disease - European Medical Journal
European Crohn´s and Colitis Organisation - ECCO - ECCO News
Congress Report
MECONIUM Study News | Peter Laboratory
European Crohn´s and Colitis Organisation - ECCO - ECCO News
ECCO 2018: Returning to a normal life with IBD - Medical Update Online
European Crohn´s and Colitis Organisation - ECCO - Why become a Corporate Member
ECCO 2022
European Crohn´s and Colitis Organisation - ECCO - Past Congresses
ECCO 2018
ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach
European Crohn´s and Colitis Organisation - ECCO - Paediatric news from the 13th Congress of ECCO 2018
MIRRI - Microbial Resource Research Infrastructure - Several MIRRI members attended the 38th Congress of the European Culture Collections' Organisation (ECCO) held in Moscow from 13 to 15 September 2018. Serge Casaregola,
InDex Pharmaceuticals presents mechanism of action data for cobitolimod at the ECCO congress
Gianluca Pellino on Twitter: "@EuroSurg 1 poster on at 11 ECCO Congress in Amsterdam. We are spreading! https://t.co/VnibnJrvlu" / Twitter
ECCO - European Crohn's and Colitis Organisation | eMedEvents
European Crohn´s and Colitis Organisation - ECCO - Past Congresses
European Crohn´s and Colitis Organisation - ECCO - ECCO News 3/2018
E.C.C.O. (@ecco_eu) / Twitter
Inflammatory Bowel Diseases
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
ECCO 2022
European Crohn´s and Colitis Organisation - ECCO - Home
ECCO IBD by OCEAiN Organisation, Congress, Emotion, Association, iNnovation GmbH
ECCO 2018 Archives - Medical Conferences
Congreso Europeo de Cronh y Colitis Ulcerosa (ECCO 2018)
